HCM Risk Assessment Model Advanced
A groundbreaking NIH-supported study has unveiled an advanced model for predicting outcomes in hypertrophic cardiomyopathy (HCM), a common heart condition affecting 1 in 500 people. This innovative tool integrates diverse patient data to more accurately forecast adverse cardiac events, promising to revolutionize disease management and improve patient lives.